Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001493152-26-002424
Filing Date
2026-01-15
Accepted
2026-01-15 16:15:29
Documents
1
Period of Report
2026-01-12

Document Format Files

Seq Description Document Type Size
1 4/A ownership.html 4/A  
1 4/A ownership.xml 4/A 3827
  Complete submission text file 0001493152-26-002424.txt   5354
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Issuer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CATALYST BIOSCIENCES, INC. 611 GATEWAY BOULEVARD, SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address
Ling Geoffrey M.D. (Reporting) CIK: 0001800097 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38914 | Film No.: 26536437